The systematic study of cellular reactions to purified chemical fractions of the tubercle bacillus was first demonstrated by Sabin and her co-workers. '5 16, 17, 18 These chemically purified derivatives were prepared by Anderson of Yale. The above studies have contributed greatly to our knowledge of the pathogenesis of tuberculosis. Throughout all of the above work, however, no one specific factor was isolated to which the so-called "virulence" of the bacillus can be attributed. There has likewise as yet been no chemical evidence forthcoming which has shed any light upon the chemical differentiation between virulent and avirulent strains. Sabin et al. have shown, however, that the lipoid substances have exceeded all others in their ability to act as stimulants and maturation factors in the life cycle of the epithelioid cells of the host. This cellular phenomenon was demonstrated repeatedly with the phosphatide fraction of the bacillus. Later it was found that phthioic acid, a new fatty acid isolated by Anderson from the phosphatide fraction, was by itself capable of stimulating monocytes and epithelioid cells resulting in the formation of the tuberculous tissue. Although much work has been done with the phosphatide fraction, there has been no evidence assigning the latter to any specific role in the immunological mechanism of the disease. A great deal of investigation has been devoted to the antigenic properties of the lipoids, including fats, compound lipoids such as the phosphatides,1 4 5 cerebrosides, and the derived lipoids; also those substances obtained from the simple and compound lipoids by hydrolysis, e. g., sterols and fatty acids. Recently, Gerstl and his co-workers,6 using mycolic acids derived from the waxes of human, bovine, and avian tubercle bacilli, and from the leprosy bacillus, demonstrated that these hydroxy acids are responsible for the presence and persistence of the necrotic lesions induced by the above bacilli, but are not related to the elective pathogenicity of these different strains.
of other workers' that lipoid substances stripped of all bacillary debris, protein, carbohydrates, etc. are not related to virulence or native resistance. In combination with other chemical components, however, whether within the living organism or in isolated form from the latter, the subject of lipoid specificity becomes one which deserves much further study. Some light might be shed on the nature of lipoid complexes by techniques which would permit isolation in pure condition of the various lipoids obtained by alcoholic or ether extractions of bacteria and tissues. Such complexes as the 0 and Vi antigens from the typhoid bacillus, the Forssmann body, the human blood groups, might serve as logical starting points. The successful development of such techniques might well lead to the isolation of a "P" factor, as discussed by Middle- brook,'3 namely, "that factor or component within the organism having the capacity for causing progressive tuberculosis by bacterial multiplication in vivo." It was previously shown by one of the authors9 that a protein-free polysaccharide fraction from the human strain bacillus H37, elicited certain cellular and immunological responses, when given repeatedly and in increasing doses, in animals and human beings. In due course of these studies observations were made with other carbohydrate proteinfree fractions isolated from the tubercle germ mass; some of these fractions contained lipoid substances in varying amounts. Some of the latter were tested in small groups (6 to 12) of animals using an equal number for controls. It was found that the lipoid-containing fractions conferred a much greater degree of immunity against subsequent infection than did the carbohydrate fractions free from lipoidal material. Even though the number of animals used in these preliminary trials was small, we felt the degree of protection conferred warranted further study. Consequently a lipoid-carbohydrate complex was isolated (as described below) and used in the present laboratory and clinical investigations.
Materials and methods
The complex was isolated from alcohol-ether extracts of virulent H37 bacilli. The bacilli were grown on Long's synthetic medium for a period of 6 to 8 weeks. The cultures were then filtered through Buchner funnels and placed in a mixture of equal parts of alcohol and ether. This mixture was allowed to stand at room temperature with intermittent shaking for a two-week period. The bacilli were again filtered through Buchner funnels and the filtrate saved. The filtrate was passed through a Berkefeld filter and placed over a steam-bath and allowed to evaporate until a sticky residue remained. The residue was extracted with ether until no further amber color appeared in the 28 CARBOHYDRATE-LIPOID THERAPY OF TUBERCULOSIS extract. To the pooled ether washings was added 95 per cent alcohol until no further precipitation occurred. The precipitate was separated by centrifugation and when dried formed a thin opalescent scale. In a mortar this scale was ground to a powder from which aliquots were taken to make up the desired aqueous concentrations.
The product when ready for animal testing was free from protein and protein-nitrogen according to the Biuret, ninhydrin, and sodium fusion tests. It gave an intense Molisch reaction and did not show reducing sugars until hydrolyzed with 5 per cent sulfuric acid. It formed typical glucosazones with phenylhydrazine hydrochloride. The complex was slowly soluble in water and formed an opalescent solution. Further chemical study of the complex is now being undertaken.
Toxicity
The tests for toxicity were carried out in tuberculous and in nontuberculous guinea-pigs and rabbits. It was found that tuberculous guinea-pigs succumbed to 5 mg. given intraperitoneally within 48 hours. Non-tuberculous animals tolerated the above amount, but died at the end of 72 hours from 20 mg. given by the same route. Normal rabbits tolerated 3 mg. intravenously without manifesting any untoward effects. Repeated intravenous and subcutaneous injections of the complex were given to rabbits and guinea-pigs, respectively, to rule out the possibility of allergy and anaphylaxis. The rabbits received a total of 50 mg. intravenously. They were then permitted to go untreated for two weeks, at the end of which time they were given 3 mg. intravenously.
There was no sign of any symptoms (rise in temperature, in breathing, etc.) in any of the rabbits or guinea-pigs so tested. Subcutaneous and intracutaneous injections were also made with the complex. It was found that 1 mg. given intracutaneously produced an induration with erythema in both the normal and the tuberculous guinea-pig. When this amount was increased to 4 mg. abscess formation occurred in the tuberculous animal within the following three or four days.
Post-mortem examinations performed on animals (tuberculous and non-tuberculous) that It will be seen in table 1 that all of the control animals died of tuberculosis with one exception. Sections of the liver, spleen, and lung of this animal were studied microscopically and no evidence of disease was seen in any of the above-mentioned organs. The inguinal and tracheo-bronchial lymph nodes, however, were enlarged and contained caseous cores. Smears made from the caseous material of these glands showed acid-fast bacilli.
It is of interest to note that the animal which was the largest in the control group at the beginning of the experiment (455 gm.) at the time of death weighed 585 gm. Of the treated animals that died of tuberculosis the gross and microscopic pathology was typical in all respects. In the immunized animals where the extent of disease was ++, sections made for microscopic study of the infected organs showed a healed type of disease; that is, the tubercles seen in these sections were without central necrosis and were accompanied by a considerable amount of fibrosis. A few scattered acid-fast bacilli were demonstrable, however, in the lesions of these organs. All of the treated animals which were sacrificed had shown a progressive gain in weight throughout the experiment. It would seem from the microscopic sections studied that the resistance in the treated animals (with three exceptions) had been increased to such a degree that the establishment of generalized disease was retarded. We are unable, as yet, to account for the extent of disease seen to develop in the three treated animals which succumbed to the disease.
Following the above experiment it was decided to test the therapeutic properties of the complex, as well as to repeat the prophylactic experiment, and to use a larger number of animals. For this purpose 58 animals were selected, 20 for prophylaxis, 20 for therapeutic treatment, and 18 as controls. The infecting dose was 0.01 mg. of virulent strain H37 given subcutaneously in the right groin. An interval of 30 days was allowed to elapse before treatment with the complex was started on any of the animals. The amount of complex administered, the route of injections, and the period of treatment were the same for this prophylactic group as in the first experiment. The therapeutic group was treated bi-weekly for a six-week period, during which time these animals received the same amount of the complex (6 mg.) as the prophylactic group. No further treatment of any kind was given to this group. The results are presented in table 2. in this experiment at the end of the third month. It will be noted from table 2, however, that there is a significant difference in the degree of tuberculosis present in the treated and in the control animals. A difference is also seen in the prophylactic and therapeutic groups. The contrast in the latter instance may be due to the toxicity of the complex (rise in temperature in non-tubercular animals) in addition to the superimposed pneumonic infection. Microscopic sections made from the organs of the sacrificed animals, in both the prophylactic and therapeutic groups where the tuberculous process was not complicated by pneumonia, were similar to those observed in the first experiment. The degree of fibrosis was not so great as that seen in the first experiment, however. Even though we were forced to terminate this experiment prematurely, we feel justified in concluding that the trend of this experiment paralleled that of the first. The experiment is now being repeated.
Since there was a considerable degree of protection conferred on the animals in the above experiment, we were interested in determining if possible the nature of the mechanism elicited by injections of the complex in the animal body. For this purpose two avenues of approach were considered, namely, the serological and hematological. Serologically, tests for the presence of precipitin-type antibody were made with a variety of sera. The results of the tests appear in table 3. hours. These tests were so sharply defined that only two symbols (+) and (-) were used to designate positive or negative results. The concentration of the complex in the above tests was the same as that used for injection purposes (1 mg. per cc.). The concentration of the serum was likewise unaltered. In some instances, however, where negative tests were obtained variations in both serum and complex concentrations were made, but without producing any effect upon the negativity of the test. The fact that all the sera from normal and from immunized rabbits gave positive tests cannot be explained at this time. We feel that the results of the serological tests are too inconsistent to permit association with any specific humoral (antibody) defense mechanism. Experiments are presently under way, however, which we feel will yield more conclusive evidence as to the nature of the serological reactivity of this carbohydrate-lipid complex.
The possibility that some one of the cellular elements of the blood might reflect the mechanism of protection stimulated by injections of the complex was also considered. For this purpose it was decided to follow the trend of the differential blood picture for two weeks previous to any injection of the complex in both the tuberculous patients and animals. The counts were taken at 10 A. M. each day during the two-week period and were continued for one month after injection of the complex was started in both the human and animal groups. The counts were made 24 hours after each injection of the complex. It was found that the fluctuations in all of the cellular elements after each injection were very similar to those seen in the series of counts taken before injections were started. Wright's stain was used throughout and 100 cells were counted in each instance.
Discussion of laboratory results
One can well be led into an unending and inconclusive discussion when attempting to isolate any specific factor in the chemotherapy and serology of tuberculosis. The subject of enzyme specificity in tuberculosis has recently been given support by the work of Gerstl and his co-workers5 at Yale. These workers feel that the splitting of the tubercle phosphatide by enzymes extracted from the lung, liver, and kidney represents a cellular mechanism vitally concerned with resistance to tuberculosis. In the present paper it is seen that no one specific factor was isolated which could be intimately associated with the resistance observed in the treated animals. In view of these observations one can 34 logically look to a possible intracellular mechanism. This mechanism can -be seen in the light of two possibilities (a) an enzyme system,5 and (b) the intracellular antibody phenomenon as first suggested by Man Regardless of which of the two systems is involved in the resistance mechanism in tuberculosis, one or possibly both may function in the effort of the fixed or the wandering cell to retard the multiplication of tubercle bacilli or greatly to limit the damaging effect of a specific component in the tubercle bacillus to which virulence might be attributed. We know also from the work of Lurie"0 that the activity of the phagocyte from immunized (tuberculous) animals is far greater than that seen in the phagocyte of the normal animal. This observation was made by .Kolmer.8 Sabin et al. 15 16, 17 have repeatedly demonstrated the reaction of cells (fixed and wandering) to injections of lipoid derivatives from tubercle bacilli. In no instance during their studies, however, did these workers ascribe any immunological specificity to any of the derivatives or the cellular elements reacting to injections of the former.
Pinner,'4 on the other hand, working with a highly purified phosphatide fraction prepared by Anderson, has found that this fraction reacts in vitro with the serum of tuberculous patients and animals in precipitin and complement fixation tests and is also capable of stimulating specific antibody production in animals. The latter work likewise confirms the earlier work of Boquet and Negre,2 who used a less purified preparation of the phosphatide. From our own observations with the complex mentioned here the humoral (antibody) factors as well as the fluctuations seen in the cellular elements following injections of the complex in both man and animals could not be correlated with either clinical improvement or decline.
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Due to the absence of any known specific factor and until further experiments now under consideration are completed, we feel justified in believing that some of the beneficial results seen in both man and animals might possibly be due to the intracellular mechanism mentioned above. With the background of experimental work, there is sufficient justification for the therapeutic use of these fractions of the tubercle bacilli either alone or in combination. The low toxicity of these derivatives, as contrasted with tuberculo-protein, permits of considerable freedom in their use.
Clinical application
Even though bacteriolytic or bacteriostatic action may be negligible, the lipo-polysaccharide suspension may offer some aid to the body contending with a chronic destructive process. Furthermore, evidence is slowly accumulating that the intracellular (alkaline and acid phosphatide) enzyme systems of the lung and liver actively respond to the parenteral use of this combination. The latter work is presently going on in our laboratory.
Our clinical study has been under way for more than two years. Such reports as are made are based upon cases where recovery has taken place and appears likely to be permanent and upon others where steady sustained progress justifies optimism as to the final outcome.
Pulmonary tuberculosis
Only pulmonary tuberculosis has been under treatment, with secondary infections in the bronchi in one case and with typical tubercular laryngitis in two others. All of the cases selected fall into one 36 group; that is, unfavorable or even hopeless. As subdivisions there are those classed as unstable in the young adult; those with postoperative spread; the old fibroid; and the fibro-cavernous.
It is therefore apparent that the therapeutic test of the lipopolysaccharide has been a rigid one, with little prospect, even at the outset, of a high percentage of favorable results.
In 10 of a group of 14 cases, chosen because of their marked instability, the results have been favorable. All of this number had previously had the benefit of routine sanatorium treatment. The pulmonary process had been temporarily arrested only to show renewed activity under normal living conditions. In half of this number this had occurred more than once. At the present time all 10 cases are well arrested and serial x-ray films denote well-marked fibrosis. Some have been working for from six months to one year. In such patients where routine treatment has failed to give lasting results, the possibilities attendant upon the use of biological products should be thoroughly explored.
The four remaining patients, suffering from extensive, rapidly advancing disease, failed to respond to treatment and no check upon the progress of the infection was noted.
A series of 10 cases in which an active lesion developed or increased in extent during treatment with pneumothorax or subsequent to thoracoplasty or pneumonectomy, have been given a course of inoculations for a period of three to five months.
To appraise the value of the fraction in these patients is difficult, since retrogression occurs from the effects of surgery alone. A distinctively favorable impression has been gained, however, based partly on the development of better appetite, increased sense of well-being, consistent gain in weight, as well as x-ray evidence of retrogression of exudative lesions in the contralateral lung.
A third section of our series has consisted of 13 bilateral or advanced fibro-cavernous cases. Of these, most had long-standing disease and more than one cavity. A preliminary period of sanatorium treatment, in all but one case, of from six months to five years gave a control background. No rapid change in the x-ray picture could be expected, but as the patient gradually built up increased tolerance to the lipo-polysaccharide, the reaction of the pulmonary tissue was noticeable and progressive. In three cases in which the excavated area was larger than 
Local reactions
The local reaction which has followed the subcutaneous injection has been used as a guide in the use of the lipo-polysaccharide preparation. In 18 to 24 hours an area of erythema has appeared varying in size from 2 to 10 cm., accompanied with heat and induration. In 48 hours the redness has disappeared leaving a firm local injection point. Its absorption varied, often lasting a week. Occasionally subsequent injections gave rise to an Arthus' phenomenon. As the duration of the treatment increased, the local reaction has become less marked and, with increasing doses, often failed to appear even when full amounts were injected.
In the first preparation used, the lipid content was sufficiently concentrated to cause such a marked local reaction that in three patients the area broke down and yielded a serous secretion for from two days to four weeks. Healing then took place leaving an indurated scar. These reactions led to a modification of the lipid content. In the past year only one such injection site softened and discharged. 
Comment
The natural reaction of the phthisiologist to any new or partly tried method of treating tuberculosis is that of extreme skepticism. Spectacular results from bed rest alone are not infrequent, especially in the shortlived exudative lesion. Controlled observations are therefore desirable, but in a disease of so great diversity of form difficult of attainment.
The solution may lie in a selection of only the grave case for treatment, or in instituting treatment only after the failure of a substantial period of sanatorium care.
In the present series, one or both of these conditions pertain and on this account some optimism is justified at the recorded results. The possibilities of the use of combined fractions of the tubercle bacillus in the treatment of phthisis, either with more potent products or possibly with type-specific carbohydrate are an unexplored field. They offer promise of therapeutic results used alone or in conjunction with some antibiotic. Summary A lipo-polysaccharide fraction of the tubercle bacillus has been found to have some therapeutic value in the treatment of pulmonary tuberculosis. The clinical results are more suggestive because of the severity of the type of case treated. The possibilities of this line of treatment justify further investigation.
